These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2178250)

  • 21. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG; Neal DE; Simmons NL
    J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed onset of the amnestic effect of posttraining beta-endorphin: effects of propranolol administered prior to retention testing.
    Izquierdo I; McGaugh JL
    Eur J Pharmacol; 1985 Jul; 113(1):105-8. PubMed ID: 2995052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors.
    Botella A; Rekik M; Delvaux M; Davicco MJ; Barlet JP; Frexinos J; Bueno L
    Endocrinology; 1994 Nov; 135(5):2160-7. PubMed ID: 7525262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
    Pozo D; Montilla ML; Guerrero JM; Calvo JR
    Eur J Pharmacol; 1997 Mar; 321(3):379-86. PubMed ID: 9085051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
    Rodríguez-Pena MS; Guijarro LG; Prieto JC
    Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholecystokinin downregulates receptors for vasoactive intestinal peptide and secretin in rat pancreatic acini.
    Katsushima S; Adachi H; Honda T; Sato S; Kusui T; Onishi S; Aoki E; Noguchi M; Konishi J
    Am J Physiol; 1990 Mar; 258(3 Pt 1):G395-403. PubMed ID: 2156442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of memory processing by neuropeptide Y varies with brain injection site.
    Flood JF; Baker ML; Hernandez EN; Morley JE
    Brain Res; 1989 Nov; 503(1):73-82. PubMed ID: 2611661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of acute arecoline, tacrine, and arecoline + tacrine post-training administration on retention in late middle-aged mice.
    Flood JF
    J Gerontol; 1988 Mar; 43(2):B54-6. PubMed ID: 3346520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of vasoactive intestinal polypeptide in the adaptation of intestinal smooth muscle cells to mechanical distension.
    Rekik M; Delvaux M; Frexinos J; Bueno L
    J Pharmacol Exp Ther; 1998 Dec; 287(3):832-8. PubMed ID: 9864261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral actions of vasoactive intestinal peptide (VIP).
    Cottrell GA; Veldhuis HD; Rostene WH; de Kloet ER
    Neuropeptides; 1984 Jun; 4(4):331-41. PubMed ID: 6089028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of prepro-vasoactive intestinal peptide-derived peptides on the murine immune response.
    Yiangou Y; Serrano R; Bloom SR; Peña J; Festenstein H
    J Neuroimmunol; 1990; 29(1-3):65-72. PubMed ID: 2170441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of intraventricular administration of vasoactive intestinal polypeptide on body temperature in the rat.
    Itoh S; Hirota R
    Jpn J Physiol; 1982; 32(4):677-81. PubMed ID: 6129338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.
    Gozes Y; Brenneman DE; Fridkin M; Asofsky R; Gozes I
    Brain Res; 1991 Feb; 540(1-2):319-21. PubMed ID: 1647246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations.
    Morris JL; Murphy R
    Eur J Pharmacol; 1989 Mar; 162(2):375-9. PubMed ID: 2542061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of amylin on memory processing using peripheral and central routes of administration.
    Flood JF; Morley JE
    Peptides; 1992; 13(3):577-80. PubMed ID: 1523170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of memory retention by neuropeptide K.
    Flood JF; Baker ML; Hernandez EN; Morley JE
    Brain Res; 1990 Jun; 520(1-2):284-90. PubMed ID: 2169954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat.
    Weick RF; Stobie KM; Noh KA
    Neuroendocrinology; 1992 Nov; 56(5):646-52. PubMed ID: 1488097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Septo-hippocampal drug interactions in post-trial memory processing.
    Farr SA; Uezu K; Flood JF; Morley JE
    Brain Res; 1999 Nov; 847(2):221-30. PubMed ID: 10575091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term memory formation in chicks is blocked by 2-deoxygalactose, a fucose analog.
    Rose SP; Jork R
    Behav Neural Biol; 1987 Sep; 48(2):246-58. PubMed ID: 3675519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.